The latest biotech news - Labiotech.eu

Home News and Trends Page 335

Latest Posts

News and Trends 6 Jan 2016

Audi Strengthens Collaboration with French Biotech for the Future of Automotive Biofuels

Audi is entering a renewed collaboration agreement with French Global Bioenergies to further broaden the flexibility of their biofuels technology for Greener Cars. The Paris based Global Bioenergies approach to second-generation isobutene production (using non-edible sources of biomass – e.g. wood chips) has turned out to be hugely popular, earning a €1.4M investment back in […]

January 6, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 6 Jan 2016

Growing Mini-Brains in Labs to Better Understand Neurological Disease

Mini brains, about 3-4 mm are a breakthrough in Neurology which will enable researchers to study the development of neurological disease and perform drug tests ex vivo. Scientists from Institute of Molecular Biotechnology (IMBA) in Vienna are underpinning the secrets behind the most fascinating human’s organ, the brain. By essentially growing brains from scratch, the […]

January 6, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 5 Jan 2016

Say Goodbye to Post-Operation Nausea with this Phase III UK Trial Success

An anti-vomiting medication for post-operative patients has smashed its phase III trial in the UK in one of the largest ever post-operation-nausea studies…ever. Roll on FDA approval. Acacia Pharma is a Cambridge based clinical-stage biotech which looks to provide supportive care of patients with debilitating conditions arising as a consequence of surgery, cancer or cancer treatment. […]

January 5, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 5 Jan 2016

How these Latest Trials Prove PD-L1 as The Breakthrough Trend in Immuno-Oncology that is Here to Stay…

By targeting platinum resistant Ovarian cancer, Avelumab is a new anti-PD-L1 checkpoint inhibitor on the Cancer block. This just affirms how PD-L1 receptor is seen as the current breakthrough therapeutic target in Immuno-Oncology. Program-Death ligand 1 (PD-L1) is already a common target for mAbs in immuno-oncology. If expressed on the tumor cells, this enables the […]

January 5, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 4 Jan 2016

Biotech and €6M to Save Orangutans? How a Yeast Alternative to Palm Oil could Stop Deforestation

Armed with a €6M Industry Grant, the Universities of Bath and York in the UK are researching how Yeast could provide a Palm-Oil alternative and save our Great Apes from deforestation… Palm oil is an edible vegetable oil derived from the mesocarp (reddish pulp) of the fruit of the oil palms – primarily the African oil palm Elaeis guineensis. However, although hugely […]

January 4, 2016 - 3 minutesmins - By Joachim Eeckhout

News and Trends 4 Jan 2016

French Nano-Xrays to Kill Prostate Cancer in Phase I/II Trial

A Parisian Nanomedicine biotech is using it’s proprietary NanoXray technology to enhance radiotherapy. Now a candidate to treat Prostate cancer has received FDA approval for a phase I/II trial in the US. Nanobiotix is seeking to develop NBTXR3 for patients with intermediate and high-risk prostate cancer, with the aim of providing effective tumor destruction and […]

January 4, 2016 - 3 minutesmins - By Dani Bancroft

ADVERTISEMENT

News and Trends 4 Jan 2016

Cellectis Full-Steam Ahead with UCART19 Trial for Leukemia in the UK

So it begins…dubbed the ‘Miracle Cure’ for Blood Cancer, UCART19 is now set to begin its journey to Human trials in the UK. Just 2 days before Christmas, the French billion euro Biotech, Cellectis, submitted a clinical trial application to the Medicines & Healthcare products Regulatory Agency (MHRA). Specifically, the request was to approve initiation […]

January 4, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 4 Jan 2016

Genomics’ Holy Grail: The Secret to Super-Longevity Lies in your Genes

The search for the Holy Grail in aging has long been a focus in regenerative medicine, which poses the question: why do some of us age better than others? Now growing evidence in Genomic Studies shows that there are key genetic players in the Aging game… Ever since the Human Genome Project, which began 25 […]

January 4, 2016 - 4 minutesmins - By Dani Bancroft

News and Trends 31 Dec 2015

Did you Know the Biotech Processes behind Wine and Champagne?

Besides bread based confections, making alcohol from fruit is one of the oldest biotech processes. But what is really behind the transformation of grapes into wonderful wines, or even champagne? Colorful beverages As we are talking about biotechnology, it is crucial to discuss the micro-organisms involved in the process. But I think you would also love to […]

December 31, 2015 - 4 minutesmins - By Jerome Topsent

News and Trends 30 Dec 2015

Who Tried to Save the World in 2015? The Coolest Developments in GreenTech this year…

Biofuels, bioplastics, Moss-based drugs and algae for food. All of these are pioneering areas of GreenTech progress this year. So what are the major developments in this forward-thinking field? 1. 100% Biodegradable Potato Plastics The Italian company Bio-On from Bologna is specialized in the production of environmentally sustainable materials, including Minverv PHAs. These are ‘green’ […]

December 30, 2015 - 5 minutesmins - By Dani Bancroft

News and Trends 30 Dec 2015

3 EU Biotechs which Over-performed in 2015

2015 was a crazy year for the Biotech industry, probably the craziest since the birth of the industry 40 years ago. I looked back on this year and here’s my personal top 3 of EU Biotechs which over-performed. I sorted them out in top partnerships, clinical trials and fundraising. (Of course, this lists is not […]

December 30, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 29 Dec 2015

The 3 Worst Biotech Scandals of 2015!

2015 was tarnished by scandals that will certainly stay in minds for a long time (just need to mention the FIFA and Volkswagen to give you an idea). The Biotech world has not been spared by scandals and here is a quick overview of the worst of this year! I’m intentionally keeping it short but several […]

December 29, 2015 - 3 minutesmins - By Joachim Eeckhout

ADVERTISEMENT